Back
CI Alternative Investment Grade Credit ETF USD Hdg Vs. Janux Therapeutics Industry Stock Comparison
Buy
62
CRED.U.TO
CI Alternative Investment Grade Credit ETF USD Hdg
Last Price:
$20.61
Seasonality Move:
0.27%
Sell
23
JANX
Janux Therapeutics
Last Price:
$50.53
Seasonality Move:
80.32%
Buy
62
CI Alternative Investment Grade Credit ETF USD Hdg (CRED.U.TO)
is a Buy
Is CI Alternative Investment Grade Credit ETF USD Hdg a Buy, Sell or Hold?
-
The current CI Alternative Investment Grade Credit ETF USD Hdg [CRED.U.TO] share price is $20.61. The Score for CRED.U.TO is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
CRED.U.TO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy, Sell or Hold?
-
The current Janux Therapeutics [JANX] share price is $50.82. The Score for JANX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CRED.U.TO Stock Price Chart
What is CI Alternative Investment Grade Credit ETF USD Hdg's stock price today?
-
The CI Alternative Investment Grade Credit ETF USD Hdg share price today is $20.61Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRED.U.TO is experiencing slight buying pressure.
JANX Stock Price Chart
What is Janux Therapeutics's stock price today?
-
The Janux Therapeutics share price today is $50.82Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.
CRED.U.TO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.06 | Buy |
Relative Strength Index (14 RSI): | 99.99 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.38 - 20.56) | Buy |
Bollinger Bands (100): | (20.19 - 20.45) | Buy |
JANX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.52 | Sell |
Relative Strength Index (14 RSI): | 41.88 | Sell |
Chaikin Money Flow: | -1994706 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (53.74 - 62.68) | Sell |
Bollinger Bands (100): | (44.76 - 56.7) | Buy |
CRED.U.TO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.61 | Sell |
20-day SMA: | 20.49 | Buy |
50-day SMA: | 20.41 | Buy |
200-day SMA: | 20.05 | Buy |
8-day EMA: | 20.58 | Buy |
20-day EMA: | 20.52 | Buy |
50-day EMA: | 20.42 | Buy |
200-day EMA: | 20.06 | Buy |
JANX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 53.68 | Sell |
20-day SMA: | 56.78 | Sell |
50-day SMA: | 54.64 | Sell |
200-day SMA: | 47.7 | Buy |
8-day EMA: | 54.12 | Sell |
20-day EMA: | 55.17 | Sell |
50-day EMA: | 54.12 | Sell |
200-day EMA: | 45.19 | Buy |
CI Alternative Investment Grade Credit ETF USD Hdg Earnings Growth & CRED.U.TO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Janux Therapeutics Earnings Growth & JANX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and a decrease next year of $0.75 per share.
CI Alternative Investment Grade Credit ETF USD Hdg Technical Analysis
Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 24 | Dec 27 | Dec 30 | Jan 2 | Jan 6 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
17 | 18 | 19 | 20 | 24 | 27 | 30 | 02 | 06 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Janux Therapeutics Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |